Zhejiang Shapuaisi Pharmaceutical Co Ltd Total Liabilities
Zhejiang Shapuaisi Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has total liabilities worth CN¥513.25 Million CNY (≈ $75.10 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Zhejiang Shapuaisi Pharmaceutical Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Total liabilities of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024. This chart illustrates how Zhejiang Shapuaisi Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Zhejiang Shapuaisi Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Shapuaisi Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nano Dimension Ltd
NASDAQ:NNDM
|
USA | $75.28 Million |
|
Sermsang Power Corporation Public Company Limited
BK:SSP
|
Thailand | ฿17.53 Billion |
|
Shandong Swan Cotton
SHG:603029
|
China | CN¥1.40 Billion |
|
Kingstone Companies Inc
NASDAQ:KINS
|
USA | $348.77 Billion |
|
Xinlong Holding Group Co Ltd
SHE:000955
|
China | CN¥152.91 Million |
|
Sungwoo Hitech Co. Ltd
KQ:015750
|
Korea | ₩3.01 Trillion |
|
Escalade Incorporated
NASDAQ:ESCA
|
USA | $51.89 Million |
|
China Metal Products Co Ltd
TW:1532
|
Taiwan | NT$33.83 Billion |
Liability Composition Analysis (2008–2024)
This chart breaks down Zhejiang Shapuaisi Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) total assets.
Liquidity & Leverage Metrics
Zhejiang Shapuaisi Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Zhejiang Shapuaisi Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Shapuaisi Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
The table below shows the annual total liabilities of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥516.59 Million ≈ $75.59 Million |
+17.16% |
| 2023-12-31 | CN¥440.92 Million ≈ $64.52 Million |
+82.96% |
| 2022-12-31 | CN¥240.99 Million ≈ $35.26 Million |
+3.48% |
| 2021-12-31 | CN¥232.89 Million ≈ $34.08 Million |
-36.51% |
| 2020-12-31 | CN¥366.78 Million ≈ $53.67 Million |
+265.75% |
| 2019-12-31 | CN¥100.28 Million ≈ $14.67 Million |
-40.10% |
| 2018-12-31 | CN¥167.41 Million ≈ $24.50 Million |
-21.08% |
| 2017-12-31 | CN¥212.13 Million ≈ $31.04 Million |
-14.43% |
| 2016-12-31 | CN¥247.88 Million ≈ $36.27 Million |
-35.34% |
| 2015-12-31 | CN¥383.37 Million ≈ $56.10 Million |
+250.29% |
| 2014-12-31 | CN¥109.44 Million ≈ $16.01 Million |
-55.19% |
| 2013-12-31 | CN¥244.26 Million ≈ $35.74 Million |
+0.80% |
| 2012-12-31 | CN¥242.33 Million ≈ $35.46 Million |
+93.19% |
| 2011-12-31 | CN¥125.43 Million ≈ $18.35 Million |
+78.04% |
| 2010-12-31 | CN¥70.45 Million ≈ $10.31 Million |
-8.68% |
| 2009-12-31 | CN¥77.15 Million ≈ $11.29 Million |
+11.42% |
| 2008-12-31 | CN¥69.24 Million ≈ $10.13 Million |
-- |
About Zhejiang Shapuaisi Pharmaceutical Co Ltd
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi… Read more